JANSSEN PHARMS FDA Approval NDA 019037

NDA 019037

JANSSEN PHARMS

FDA Drug Application

Application #019037

Application Sponsors

NDA 019037JANSSEN PHARMS

Marketing Status

Discontinued001

Application Products

001SOLUTION;ORAL1MG/5ML0IMODIUMLOPERAMIDE HYDROCHLORIDE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1984-07-31STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1986-06-02STANDARD
LABELING; LabelingSUPPL3AP1987-06-16STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 19037
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"IMODIUM","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"1MG\/5ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"IMODIUM","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"1MG\/5ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.